EDTUTC-4 New YorkLog in Sign up

MSLE
Satellos Bioscience Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:43 PM EDT

8.42USD-1.405%(-0.12)27,669

Loading…

Loading…

178.22M

Previous Close

$8.50

Beta

1.75

52-Week High

$13.39 2026-03-03

52-Week Low

$5.44 2026-06-24

SMA 50

$9.45

SMA 200

$8.50

Avg. Vol 10D

83,838

Avg. Vol 30D

46,402

Avg. Vol 90D

52,998

Relative Vol

0.60

21.22M

1.06M

5.01%

82,427

Short Interest %

7.75%

2.58

On/Off Exchange

60%/40%

55.17%

Short Vol % (off-exch)

21.04%

4.7000%

650,000

81

173

402

Nov 13, 2026 (39d)

Sep 30, 2026

07:03 AM EDTSatellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy ·

Financial Post

Sep 24, 2026

07:00 AM EDTSatellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development ·

GlobeNewswire Inc.

Sep 15, 2026

07:00 AM EDTSatellos to Present at the 31st Annual Congress of the World Muscle Society ·

GlobeNewswire Inc.

MSLE Performance

Period	Price	Date	Change	Beta
1W	8.81	2026-09-28	-4.65%	1.959
1M	8.97	2026-09-04	-6.36%	-0.030
3M	8.27	2026-07-06	+1.57%	0.663
6M	5.65	2026-04-06	+48.67%	1.712
1Y	11.25	2026-02-06	-25.33%	1.754

MSLE Stock Summary

Satellos Bioscience Inc. Common Stock (NASDAQ:MSLE) stock price today is $8.40, and today's volume is 27,736. MSLE is down 1.176% today. The 30 day average volume is 46,402. MSLE market cap is $178.22M with 21.22M shares outstanding.